Changes in Tumor Metabolism as Readout for Mammalian Target of Rapamycin Kinase Inhibition by Rapamycin in Glioblastoma

Wei Liu(University of California, Los Angeles), Wolfgang Weber(Nuklearmedizinische Klinik des Klinikums rechts der Isar), Helen C. Su(National Institute of Allergy and Infectious Diseases), Isabel J. Hildebrandt, Michael E. Phelps(National Academy of Engineering), Johannes Czernin(University of California, Los Angeles)
Clinical Cancer Research
June 1, 2008
10.1158/1078-0432.ccr-07-1824
Cited by 84

Related Papers

Quantitation in Positron Emission Computed Tomography
|Journal of Computer Assisted Tomography|1979|1.2k
Systems Biology and New Technologies Enable Predictive and Preventative Medicine
|Science|2004|1.1k
Positron Emission Tomography in Evaluation of Dementia
|JAMA|2001|952
Immune dysregulation in human subjects with heterozygous germline mutations in <i>CTLA4</i>
|Science|2014|844
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
|The Lancet Oncology|2007|808